Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers

BACKGROUND: Therapeutic options for human epidermal growth factor 2 (HER2)-positive metastatic breast cancer (mBC) are developing rapidly. This study aimed to determine the differences in the survival outcomes of patients with HER2-positive mBC in relation to access to anti-HER therapy at 3 oncology...

Descripción completa

Detalles Bibliográficos
Autores principales: Miletić, Dragana, Kraljević, Marija, Sokolović, Emir, Soče, Majana, Milović-Kovačević, Marijana, Bobić, Simonida, Cerić, Timur, Pleština, Stjepko, Bešlija, Semir, Marijanović, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243172/
https://www.ncbi.nlm.nih.gov/pubmed/37264567
http://dx.doi.org/10.12659/MSM.940356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243172/
https://www.ncbi.nlm.nih.gov/pubmed/37264567
http://dx.doi.org/10.12659/MSM.940356

Ejemplares similares